BETA Technologies, Inc. (BETA) Spending and interest coverage
- R&D / revenue · 12 months: Value 798.57%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 136.56%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 798.57% | Research and development expense / revenue. Period ending 2026-06-30. $358.10M ÷ $44.84M × 100 ≈ 798.57% |
| Stock-based compensation / revenue · 12 months | 136.56% | Share-based compensation / revenue. Period ending 2026-06-30. $61.24M ÷ $44.84M × 100 ≈ 136.56% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 358.10M USD | Research and Development Expense |
| Revenue | 44.84M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 61.24M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -506.41M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $358.10M | $44.84M | $61.24M | $-506.41M | (m) | 798.57% | 136.56% | (m) | (m) |
| 2026-03-31 | $293.77M | $36.15M | $50.87M | $-427.61M | (m) | 812.63% | 140.72% | (m) | (m) |
| 2025-12-31 | $259.89M | $35.62M | $34.76M | $-372.67M | (m) | 729.71% | 97.60% | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $206.91M | $15.09M | $12.11M | $-272.22M | (m) | 1370.99% | 80.21% | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $138.27M | $15.36M | $8.96M | $-186.57M | (m) | 900.39% | 58.35% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.